Autolus Therapeutics (AUTL) Enterprise Value Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.83% |
| Sep 30, 2025 | 44.21% |
| Jun 30, 2025 | 82.27% |
| Mar 31, 2025 | 87.20% |
| Dec 31, 2024 | 4.80% |
| Sep 30, 2024 | -156.39% |
| Jun 30, 2024 | -129.66% |
| Mar 31, 2024 | -121.21% |
| Dec 31, 2023 | 37.21% |
| Sep 30, 2023 | -57.22% |
| Jun 30, 2023 | -42.01% |
| Mar 31, 2023 | -27.69% |
| Dec 31, 2022 | -23.20% |
| Sep 30, 2022 | 5.71% |
| Jun 30, 2022 | -0.09% |
| Mar 31, 2022 | -12.13% |
| Dec 31, 2021 | -39,426.21% |
| Sep 30, 2021 | 2.92% |
| Jun 30, 2021 | -1.75% |
| Mar 31, 2021 | 1.76% |
| Dec 31, 2020 | 99.63% |
| Sep 30, 2020 | 22.64% |
| Jun 30, 2020 | 20.46% |
| Mar 31, 2020 | -29.55% |
| Dec 31, 2019 | 2.82% |
| Sep 30, 2019 | 6.66% |
| Jun 30, 2019 | -1.00% |
| Mar 31, 2019 | -56.13% |
| Sep 30, 2018 | -80.34% |